European Archives - Page 86 of 1263 - European Medical Journal

Elinzanetant in Breast Cancer

Vasomotor symptoms (VMS) can significantly affect the quality of life for women with breast cancer receiving adjuvant endocrine therapy…

Supporting Treatment Decision-Making for Lenalidomide-Refractory Multiple Myeloma Patients Post-DRd in Italy: A Multi-Criteria Decision Framework.

In these short video series, Elena Zamagni, coauthor of the EMN Research Italy publication, shares key insights on managing…

Comparison of Three Post-Prostatectomy Incontinence Therapies

Pelvic floor muscle training (PFMT) is recommended as an initial treatment for post-RP SUI, but traditional home-based approaches often lack long-term adherence.

Anti-IL-33 Antibody Shows Promise in High-Risk Patients with COPD

Tozorakimab shows potential benefit in patients with COPD with frequent exacerbations, despite primary endpoint not being met in overall population.

Does Metformin Improve Cognitive Impairment in Schizophrenia?

Learn how metformin may enhance cognitive function in schizophrenia by regulating energy metabolism and brain connectivity.

ICML 2025: Regional and Socioeconomic Disparities in CNS Lymphoma Outcomes

A large-scale national study of primary central nervous system lymphoma (PCNSL) in England has revealed stark differences in incidence and survival based on geography, age, and deprivation…

Does Magnesium Aid Glycaemic Control in Type 2 Diabetes?

Understand how magnesium supplementation modestly improves fasting glucose in Type 2 diabetes.

Real-Time Pollen Forecasting App Eases Allergy Symptoms

A recent landmark study is the first randomised, controlled trial to show clinical benefits of an allergy app for SAR sufferers.

Closing Gaps in HAE Management: Understanding What Control Means for Your HAE Patients

This symposium held during the European Academy of Allergy and Clinical Immunology (EAACI) Congress 2025 in Glasgow, UK, explores evolving…

Machine Learning Improves Liver Transplant Prediction Accuracy

While other machine learning models like MoRAL-AI and TRAIN-AI have also shown promise, TRIUMPH distinguishes itself through its robust generalisability.